Vita Imaging

Vita Imaging

Early Stage

A Revolutionary Breakthrough in Skin Cancer Detection

A Revolutionary Breakthrough in Skin Cancer Detection

Overview

Raised to Date: Raised: $131,362

Total Commitments ($USD)

Platform

Dealmaker Securities

Start Date

02/27/2024

Close Date

04/29/2024

Min. Goal
$15,000
Max. Goal
$4,120,000
Min. Investment

$570

Security Type

Equity - Common

Series

Series B

SEC Filing Type

RegCF    Open SEC Filing

Price Per Share

$5.70

Pre-Money Valuation

$40,100,000

Rolling Commitments ($USD)

Status

Active

Reporting Date

04/18/2024

Days Remaining

10

% of Min. Goal

876%

% of Max. Goal

3%

Likelihood of Max
unlikely
Avg. Daily Raise

$2,576

# of Investors

42

Momentum
cold.svg
Create a free account today to gain access to KingsCrowd analytics.
Year Founded

2018

Industry

Healthcare & Pharmaceuticals

Tech Sector

HealthTech

Distribution Model

B2B

Margin

Medium

Capital Intensity

High

Location

Fremont, California

Business Type

Growth

Vita Imaging, with a valuation of $40.1 million, is raising funds on Dealmaker Securities. The company is a medical device company developing cutting-edge cancer detection and diagnostic technology. Vita Imaging's lead product, AURA™, is a skin cancer detection device that has already been submitted for FDA clearance and is expected to launch in 2024. Vita Imaging's AURA™ is an award-winning, non-invasive imaging device that can detect Melanoma & Non-Melanoma skin cancer within two seconds. Thinh Quy Tran founded Vita Imaging in March 2019. The current crowdfunding campaign has a minimum target of $15,000 and a maximum target of $4.12 million. The campaign proceeds will be used for research and development, marketing, company employment, operations, and working capital.

Summary Profit and Loss Statement

FY 2022 FY 2021

Revenue

$0

$0

COGS

$0

$0

Tax

$0

$0

 

 

Net Income

$-837,822

$-1,112,284

Summary Balance Sheet

FY 2022 FY 2021

Cash

$46,568

$88,069

Accounts Receivable

$0

$52,589

Total Assets

$330,089

$306,849

Short-Term Debt

$294,502

$206,077

Long-Term Debt

$662,297

$623,313

Total Liabilities

$956,799

$829,390

Financials as of: 02/27/2024
Create a free account today to gain access to KingsCrowd analytics.

Raise History

Offering Name Close Date Platform Valuation/Cap Total Raised Security Type Status Reg Type
Vita Imaging 04/28/2024 Dealmaker Securities $40,100,000 $131,362 Equity - Common Active RegCF
Vita Imaging 11/12/2023 StartEngine $39,940,000 $836,957 Equity - Common Funded RegCF
Create a free account today to gain access to KingsCrowd analytics.

Price per Share History

Note: Share prices shown in earlier rounds may not be indicative of any stock splits.

Valuation History

Revenue History

Note: Revenue data points reflect the latest of either the most recent fiscal year's financials, or updated revenues directly from the founder, at each raise's close date.

Employee History

Upgrade to gain access

Pay Monthly
Annually (Save 17%)

Edge

$25 /month
billed annually
Free portfolio tracking, data-driven ratings, AI analysis and reports
Plan Includes:
Everything in Free, plus
Company specific KingsCrowd ratings and analyst reports
Deal explorer and side-by-side comparison
Startup exit and failure tracking
Startup market filters and historical industry data
Advanced company search ( with ratings)
Get Edge Annual
Already a member? Log in here.

Ratings KingsCrowd Startup Rating Methodology Article

Blurred Ratings Bars Blurred Ratings Bars

Company Updates

In this company update, we look at Vita Imaging announcing a new crowdfunding round on Dealmaker at a $40.1M valuation, reflecting its progress in FDA approval and current financial situation.

View Company Update

Founders: enhance your startup's credibility on KingsCrowd. Create an account to claim this raise page.
Add to portfolio
Vita Imaging on Dealmaker Securities 2024
Platform: Dealmaker Securities
Security Type: Equity - Common
Valuation: $40,100,000
Price per Share: $5.70

Follow company

Follow Vita Imaging on Dealmaker Securities 2024

Buy Vita Imaging's Deal Report

Vita Imaging Deal Report

Get KingsCrowd’s comprehensive report on Vita Imaging including:

  • How our proprietary algorithm rates their current capital raise (1-5 stars)
  • Detailed price, market, team, differentiators, performance, and risk ratings
  • Whether Vita Imaging is undervalued or overvalued
  • Scores on the founding team and key personnel's background and expertise

Buy the Vita Imaging deal report for only $10!

Email address:
Looking to buy more than one deal report? Get unlimited reports by upgrading to Edge